Highlight: Treatable traits—personalised medicine for life in airway disease

Posted on Wednesday 11th September 2024

Invited Review Series: Treatable traits—personalised medicine for life in airway disease

 

Series Editors: Vanessa McDonald and Peter Gibson

For close to a decade now treatable traits has been part of the respiratory community vernacular. Since the approach was proposed as a personalized medicine strategy for treating people with airway diseases, there has been a flurry of review articles, the emergence of data reporting the prevalence of traits, the impact of traits on health outcomes and the efficacy of treatable traits interventions. With this conglomeration of knowledge and evidence it is timely to think about where we are at, and where we are headed with treatable traits management. Read more…

 

Editorial

 

Treatable traits—Where we are, where we are headed

Invited Reviews

 
 
 
 

Treatable traits models of care

 

The treatable traits approach to adults with obstructive airways disease in primary and secondary care

 

Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established disease

Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established disease Issue , 2024 2024